Search Results - therapeutics+%3e+respiratory+and+pulmonary

19 Results

Sort By:

Combination Metabolic-Epigenetic Treatment for Early Lung Cancer (UCLA Case No. 2022-247)

UCLA researchers in the Division of Pulmonary Medicine at the School of Medicine uncovered a novel mechanism by which cancer cells adapt to glucose restriction and develop treatment resistance, and have in response developed a novel combination therapy to delay lung adenocarcinoma development while circumventing the development of aggressive behavior...

Published: 10/8/2025 | Inventor(s): Claudio Scafoglio

Keywords(s):

Category(s): Therapeutics > Respiratory And Pulmonary, Therapeutics > Oncology, Therapeutics > Metabolism And Endocrinology

Methods for Treating Fibrotic Diseases (UCLA Case No. 2026-025)

Contact UCLA Technology Development Group to learn more.

Published: 9/19/2025 | Inventor(s): Brigitte Gomperts

Keywords(s):

Category(s): Therapeutics > Respiratory And Pulmonary

Improving Responses to mTOR Inhibitors (UCLA Case No. 2025-205)

Contact UCLA Technology Development Group to learn more.

Published: 9/18/2025 | Inventor(s): Milica Momcilovic, David Shackelford

Keywords(s):

Category(s): Therapeutics > Respiratory And Pulmonary, Therapeutics > Oncology

Genomic Classifier for Acute Rejection After Lung Transplant (UCLA Case No. 2025-140)

Contact UCLA Technology Development Group to learn more.

Published: 9/18/2025 | Inventor(s): Stephen Weigt

Keywords(s):

Category(s): Therapeutics > Transplant, Therapeutics > Respiratory And Pulmonary

Woodfire Smoke Induced Mucociliary Airway Injury is Preventable With MEK Inhibition (UCLA Case No. 2025-088)

Contact UCLA Technology Development Group to learn more. Keywords: Airway basal stem cells, woodfire smoke, ciliary movement, lung toxicity, pharmacological intervention, respiratory molecular toxicology, wildfire smoke exposure, environmental health

Published: 9/18/2025 | Inventor(s): Brigitte Gomperts

Keywords(s):

Category(s): Therapeutics > Respiratory And Pulmonary

Monoclonal Antibodies to Human Erythroferrone (Sequences) (UCLA Case No. 2023-059)

Monoclonal Antibodies to Human Erythroferrone (Sequences) Please reach out to our office for more information.

Published: 9/12/2025 | Inventor(s): Tomas Ganz, Elizabeta Nemeth

Keywords(s):

Category(s): Life Science Research Tools, Therapeutics > Respiratory And Pulmonary

Inhalational Therapy for Tuberculosis and Mycobacterial Lung Disease (UCLA Case No. 2025-278)

UCLA researchers from the Department of Medicine have identified drug combinations that can speed up treatment of tuberculosis by being delivered intranasally as well as orally. BACKGROUND: Tuberculosis (TB) is an airborne disease caused by the bacterium Mycobacterium tuberculosis, affecting more than 10 million people worldwide each year. The standard...

Published: 8/13/2025 | Inventor(s): Marcus Horwitz, Bai Yu Clemens, Daniel Clemens

Keywords(s):

Category(s): Platforms > Drug Delivery, Therapeutics > Infectious Diseases, Therapeutics > Respiratory And Pulmonary

Targeting the SV2 Family of Proteins for Immune Regulation (UCLA Case No. 2021-122)

UCLA researchers in the Department of Medicine have identified the SV2 family of proteins as novel druggable targets for suppressing severe inflammation, including COVID-19 pneumonia. Background: In critical COVID-19, the infection causes severe inflammation and excess fluid in the lungs, leading to breathing difficulties (COVID-19 pneumonia). Recent...

Published: 8/13/2025 | Inventor(s): Ke Shuai

Keywords(s):

Category(s): Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Respiratory And Pulmonary

Targeting Plasma Extracellular Vesicles as Therapy for Severe Bacterial Pneumonia (UCLA Case No. 2025-274)

UCLA researchers in the Department of Anesthesiology & Perioperative Medicine have identified a novel method of targeting plasma extracellular vesicles to help suppress inflammation and infection during severe bacterial pneumonia. BACKGROUND: Direct and indirect lung injury such as through pneumonia or following abdominal infections can lead to...

Published: 7/17/2025 | Inventor(s): Jae Woo Lee

Keywords(s):

Category(s): Therapeutics > Infectious Diseases, Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Respiratory And Pulmonary

Use of Endogenous Plasma Extracellular Vesicles as an Adjuvant Therapeutic for Pneumonia (UCLA Case No. 2025-236)

UCLA researchers in the Department of Anesthesiology & Perioperative Medicine have developed a novel therapeutic approach using human extracellular vesicles (EVs) to block harmful effects of bacterial outer membrane vesicles (OMVs) in Pseudomonas aeruginosa pneumonia. This strategy aims to reduce inflammation, disrupt bacterial communication, and...

Published: 7/17/2025 | Inventor(s): Jae Woo Lee

Keywords(s):

Category(s): Therapeutics > Respiratory And Pulmonary, Therapeutics > Infectious Diseases

1 2